CN Stock MarketDetailed Quotes

603168 Zhejiang Shapuaisi Pharmaceutical

Watchlist
  • 8.44
  • +0.21+2.55%
Market Closed Nov 15 15:00 CST
3.20BMarket Cap-37678P/E (TTM)

Zhejiang Shapuaisi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-27.95%359.4M
-30.65%236.85M
-15.02%137.83M
17.37%644.97M
20.36%498.79M
21.94%341.55M
8.59%162.2M
-12.74%549.54M
-12.41%414.41M
-11.57%280.09M
Operating revenue
-27.95%359.4M
-30.65%236.85M
-15.02%137.83M
17.37%644.97M
20.36%498.79M
21.94%341.55M
8.59%162.2M
-12.74%549.54M
-12.41%414.41M
-11.57%280.09M
Other operating revenue
----
180.79%12.4M
----
-29.03%6.94M
----
-8.62%4.42M
----
351.89%9.77M
----
-17.35%4.83M
Total operating cost
-9.50%401.14M
-7.23%258.89M
2.91%133.51M
25.23%629.24M
19.66%443.24M
12.47%279.08M
1.34%129.73M
-13.41%502.47M
-13.07%370.41M
-11.95%248.13M
Operating cost
-18.40%179.39M
-21.60%114.98M
-8.10%67.08M
24.59%283.93M
27.09%219.84M
29.27%146.66M
33.62%72.99M
1.44%227.89M
3.78%172.97M
-11.38%113.45M
Operating tax surcharges
-5.02%4.49M
-13.74%2.8M
-27.61%1.43M
35.93%8.08M
1.17%4.73M
-0.79%3.24M
15.67%1.98M
-27.86%5.94M
-23.11%4.67M
-14.54%3.27M
Operating expense
-8.39%65.23M
9.33%42.59M
24.55%21.78M
45.09%135.33M
-5.86%71.2M
-16.33%38.95M
-33.54%17.48M
-19.84%93.28M
-7.19%75.63M
-19.70%46.56M
Administration expense
6.18%102.44M
-3.89%60.25M
10.46%30.61M
16.47%136.27M
22.27%96.47M
13.91%62.69M
9.52%27.71M
-12.02%117M
-17.64%78.9M
-4.89%55.04M
Financial expense
3,010.55%4.83M
432.37%2.7M
175.51%482.45K
194.82%1.19M
116.86%155.33K
-166.75%-811.09K
-14.03%-638.92K
70.09%-1.25M
77.70%-921.06K
89.18%-304.07K
-Interest expense (Financial expense)
134.19%6.05M
185.31%3.75M
--1.21M
180.86%4.61M
--2.58M
--1.31M
----
113.86%1.64M
----
----
-Interest Income (Financial expense)
48.10%-1.35M
40.52%-1.34M
-0.49%-948.45K
-20.30%-3.7M
-14.95%-2.59M
-88.78%-2.25M
1.64%-943.86K
39.15%-3.08M
50.57%-2.26M
58.70%-1.19M
Research and development
-11.96%44.77M
25.55%35.58M
18.88%12.13M
8.11%64.45M
29.85%50.85M
-5.91%28.34M
-50.53%10.2M
-41.68%59.61M
-51.19%39.16M
-18.44%30.12M
Credit Impairment Loss
-192.21%-3.32M
-119.73%-596.24K
214.13%558.57K
171.51%3.09M
354.26%3.6M
595.49%3.02M
-19.95%-489.42K
-151.37%-4.32M
-1,938.75%-1.41M
-278.38%-609.77K
Asset Impairment Loss
-184.25%-801.03K
-224.12%-1.47M
190.31%310.46K
-27.97%-14.52M
228.63%950.75K
275.59%1.19M
---343.77K
-472.12%-11.34M
82.74%-739.15K
107.38%315.98K
Other net revenue
6.21%20.43M
-50.39%2.62M
257.35%1.69M
-26.25%6.31M
12.10%19.23M
-65.45%5.29M
-107.35%-1.08M
57.40%8.56M
15,522.46%17.16M
1,128.69%15.3M
Fair value change income
-107.87%-34K
-107.87%-34K
---34K
-87.16%1.19M
15.36%431.96K
26.32%431.96K
----
251.42%9.27M
--374.46K
--341.96K
Invest income
58.02%21.97M
663.72%2.61M
143.20%172.04K
694.21%13.71M
660.95%13.9M
122.68%341.53K
52.49%-398.2K
-150.49%-2.31M
-33.27%1.83M
-158.77%-1.51M
-Including: Investment income associates
-43.17%2.36M
194.30%2.96M
452.78%444.2K
228.00%2.79M
--4.16M
--1M
--80.36K
---2.18M
----
----
Asset deal income
-30.01%17.79K
127.79%17.79K
--17.79K
-99.68%51.04K
-99.84%25.41K
-99.95%7.81K
----
217,692.60%15.86M
220,570.31%16.07M
83,525.33%16.07M
Other revenue
689.72%2.6M
603.93%2.1M
333.05%669.43K
99.86%2.79M
-68.36%328.88K
-57.16%298.38K
1,624.16%154.59K
-28.04%1.4M
-40.02%1.04M
68.34%696.59K
Operating profit
-128.49%-21.31M
-128.65%-19.41M
-80.83%6.02M
-60.38%22.04M
22.28%74.79M
43.35%67.76M
-12.80%31.39M
1.27%55.62M
29.87%61.16M
41.36%47.27M
Add:Non operating Income
-98.71%191.44K
-98.74%186.44K
707.66%8.09K
147,289.18%15.04M
352,749.99%14.84M
673,707,690.91%14.82M
-87.79%1K
-80.74%10.21K
-84.17%4.2K
-99.99%2.2
Less:Non operating expense
-31.27%1.87M
-45.43%1.44M
-91.75%184.11K
147.24%4M
454.75%2.73M
719.69%2.64M
801.99%2.23M
-73.46%1.62M
-88.23%491.34K
-70.87%321.51K
Total profit
-126.46%-22.99M
-125.85%-20.66M
-79.97%5.84M
-38.76%33.08M
43.22%86.9M
70.29%79.95M
-18.45%29.16M
10.51%54.01M
41.28%60.67M
45.08%46.95M
Less:Income tax cost
-29.71%5.41M
-38.89%4.16M
-76.49%1.6M
-13.89%7.97M
-50.05%7.7M
-39.91%6.8M
-16.31%6.79M
-29.94%9.26M
126.77%15.41M
109.33%11.32M
Net profit
SL-28.4M
SL-24.82M
-81.03%4.25M
-43.90%25.1M
74.99%79.2M
105.29%73.15M
-19.08%22.38M
25.51%44.75M
25.21%45.26M
32.19%35.63M
Net profit from continuing operation
-135.86%-28.4M
-133.93%-24.82M
-81.03%4.25M
-45.18%25.1M
70.33%79.2M
98.40%73.15M
-22.54%22.38M
-9.19%45.79M
28.63%46.5M
36.78%36.87M
Net income from discontinuing operating
----
----
----
----
----
----
----
92.96%-1.04M
---1.24M
---1.24M
Less:Minority Profit
1,045.11%2.35M
48.48%-102.61K
65.78%-51.05K
-35,333.41%-303.41K
---249.14K
---199.17K
---149.19K
--861.13
----
----
Net profit of parent company owners
-138.71%-30.76M
-133.70%-24.72M
-80.93%4.3M
-43.23%25.41M
75.54%79.45M
105.85%73.35M
-18.54%22.53M
25.51%44.75M
25.21%45.26M
32.19%35.63M
Earning per share
Basic earning per share
-138.10%-0.08
-135.00%-0.07
-83.33%0.01
-50.00%0.07
50.00%0.21
81.82%0.2
-33.33%0.06
27.27%0.14
27.27%0.14
37.50%0.11
Diluted earning per share
-138.10%-0.08
-135.00%-0.07
-83.33%0.01
-50.00%0.07
50.00%0.21
81.82%0.2
-33.33%0.06
27.27%0.14
27.27%0.14
37.50%0.11
Other composite income
Total composite income
-135.86%-28.4M
-133.93%-24.82M
-81.03%4.25M
-43.90%25.1M
74.99%79.2M
105.29%73.15M
-19.08%22.38M
25.51%44.75M
25.21%45.26M
32.19%35.63M
Total composite income of parent company owners
-138.71%-30.76M
-133.70%-24.72M
-80.93%4.3M
-43.23%25.41M
75.54%79.45M
105.85%73.35M
-18.54%22.53M
25.51%44.75M
25.21%45.26M
32.19%35.63M
Total composite income of minority owners
1,045.11%2.35M
48.48%-102.61K
65.78%-51.05K
-35,333.41%-303.41K
---249.14K
---199.17K
---149.19K
--861.13
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -27.95%359.4M-30.65%236.85M-15.02%137.83M17.37%644.97M20.36%498.79M21.94%341.55M8.59%162.2M-12.74%549.54M-12.41%414.41M-11.57%280.09M
Operating revenue -27.95%359.4M-30.65%236.85M-15.02%137.83M17.37%644.97M20.36%498.79M21.94%341.55M8.59%162.2M-12.74%549.54M-12.41%414.41M-11.57%280.09M
Other operating revenue ----180.79%12.4M-----29.03%6.94M-----8.62%4.42M----351.89%9.77M-----17.35%4.83M
Total operating cost -9.50%401.14M-7.23%258.89M2.91%133.51M25.23%629.24M19.66%443.24M12.47%279.08M1.34%129.73M-13.41%502.47M-13.07%370.41M-11.95%248.13M
Operating cost -18.40%179.39M-21.60%114.98M-8.10%67.08M24.59%283.93M27.09%219.84M29.27%146.66M33.62%72.99M1.44%227.89M3.78%172.97M-11.38%113.45M
Operating tax surcharges -5.02%4.49M-13.74%2.8M-27.61%1.43M35.93%8.08M1.17%4.73M-0.79%3.24M15.67%1.98M-27.86%5.94M-23.11%4.67M-14.54%3.27M
Operating expense -8.39%65.23M9.33%42.59M24.55%21.78M45.09%135.33M-5.86%71.2M-16.33%38.95M-33.54%17.48M-19.84%93.28M-7.19%75.63M-19.70%46.56M
Administration expense 6.18%102.44M-3.89%60.25M10.46%30.61M16.47%136.27M22.27%96.47M13.91%62.69M9.52%27.71M-12.02%117M-17.64%78.9M-4.89%55.04M
Financial expense 3,010.55%4.83M432.37%2.7M175.51%482.45K194.82%1.19M116.86%155.33K-166.75%-811.09K-14.03%-638.92K70.09%-1.25M77.70%-921.06K89.18%-304.07K
-Interest expense (Financial expense) 134.19%6.05M185.31%3.75M--1.21M180.86%4.61M--2.58M--1.31M----113.86%1.64M--------
-Interest Income (Financial expense) 48.10%-1.35M40.52%-1.34M-0.49%-948.45K-20.30%-3.7M-14.95%-2.59M-88.78%-2.25M1.64%-943.86K39.15%-3.08M50.57%-2.26M58.70%-1.19M
Research and development -11.96%44.77M25.55%35.58M18.88%12.13M8.11%64.45M29.85%50.85M-5.91%28.34M-50.53%10.2M-41.68%59.61M-51.19%39.16M-18.44%30.12M
Credit Impairment Loss -192.21%-3.32M-119.73%-596.24K214.13%558.57K171.51%3.09M354.26%3.6M595.49%3.02M-19.95%-489.42K-151.37%-4.32M-1,938.75%-1.41M-278.38%-609.77K
Asset Impairment Loss -184.25%-801.03K-224.12%-1.47M190.31%310.46K-27.97%-14.52M228.63%950.75K275.59%1.19M---343.77K-472.12%-11.34M82.74%-739.15K107.38%315.98K
Other net revenue 6.21%20.43M-50.39%2.62M257.35%1.69M-26.25%6.31M12.10%19.23M-65.45%5.29M-107.35%-1.08M57.40%8.56M15,522.46%17.16M1,128.69%15.3M
Fair value change income -107.87%-34K-107.87%-34K---34K-87.16%1.19M15.36%431.96K26.32%431.96K----251.42%9.27M--374.46K--341.96K
Invest income 58.02%21.97M663.72%2.61M143.20%172.04K694.21%13.71M660.95%13.9M122.68%341.53K52.49%-398.2K-150.49%-2.31M-33.27%1.83M-158.77%-1.51M
-Including: Investment income associates -43.17%2.36M194.30%2.96M452.78%444.2K228.00%2.79M--4.16M--1M--80.36K---2.18M--------
Asset deal income -30.01%17.79K127.79%17.79K--17.79K-99.68%51.04K-99.84%25.41K-99.95%7.81K----217,692.60%15.86M220,570.31%16.07M83,525.33%16.07M
Other revenue 689.72%2.6M603.93%2.1M333.05%669.43K99.86%2.79M-68.36%328.88K-57.16%298.38K1,624.16%154.59K-28.04%1.4M-40.02%1.04M68.34%696.59K
Operating profit -128.49%-21.31M-128.65%-19.41M-80.83%6.02M-60.38%22.04M22.28%74.79M43.35%67.76M-12.80%31.39M1.27%55.62M29.87%61.16M41.36%47.27M
Add:Non operating Income -98.71%191.44K-98.74%186.44K707.66%8.09K147,289.18%15.04M352,749.99%14.84M673,707,690.91%14.82M-87.79%1K-80.74%10.21K-84.17%4.2K-99.99%2.2
Less:Non operating expense -31.27%1.87M-45.43%1.44M-91.75%184.11K147.24%4M454.75%2.73M719.69%2.64M801.99%2.23M-73.46%1.62M-88.23%491.34K-70.87%321.51K
Total profit -126.46%-22.99M-125.85%-20.66M-79.97%5.84M-38.76%33.08M43.22%86.9M70.29%79.95M-18.45%29.16M10.51%54.01M41.28%60.67M45.08%46.95M
Less:Income tax cost -29.71%5.41M-38.89%4.16M-76.49%1.6M-13.89%7.97M-50.05%7.7M-39.91%6.8M-16.31%6.79M-29.94%9.26M126.77%15.41M109.33%11.32M
Net profit SL-28.4MSL-24.82M-81.03%4.25M-43.90%25.1M74.99%79.2M105.29%73.15M-19.08%22.38M25.51%44.75M25.21%45.26M32.19%35.63M
Net profit from continuing operation -135.86%-28.4M-133.93%-24.82M-81.03%4.25M-45.18%25.1M70.33%79.2M98.40%73.15M-22.54%22.38M-9.19%45.79M28.63%46.5M36.78%36.87M
Net income from discontinuing operating ----------------------------92.96%-1.04M---1.24M---1.24M
Less:Minority Profit 1,045.11%2.35M48.48%-102.61K65.78%-51.05K-35,333.41%-303.41K---249.14K---199.17K---149.19K--861.13--------
Net profit of parent company owners -138.71%-30.76M-133.70%-24.72M-80.93%4.3M-43.23%25.41M75.54%79.45M105.85%73.35M-18.54%22.53M25.51%44.75M25.21%45.26M32.19%35.63M
Earning per share
Basic earning per share -138.10%-0.08-135.00%-0.07-83.33%0.01-50.00%0.0750.00%0.2181.82%0.2-33.33%0.0627.27%0.1427.27%0.1437.50%0.11
Diluted earning per share -138.10%-0.08-135.00%-0.07-83.33%0.01-50.00%0.0750.00%0.2181.82%0.2-33.33%0.0627.27%0.1427.27%0.1437.50%0.11
Other composite income
Total composite income -135.86%-28.4M-133.93%-24.82M-81.03%4.25M-43.90%25.1M74.99%79.2M105.29%73.15M-19.08%22.38M25.51%44.75M25.21%45.26M32.19%35.63M
Total composite income of parent company owners -138.71%-30.76M-133.70%-24.72M-80.93%4.3M-43.23%25.41M75.54%79.45M105.85%73.35M-18.54%22.53M25.51%44.75M25.21%45.26M32.19%35.63M
Total composite income of minority owners 1,045.11%2.35M48.48%-102.61K65.78%-51.05K-35,333.41%-303.41K---249.14K---199.17K---149.19K--861.13--------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data